Advertisement
U.S. markets open in 4 hours 9 minutes

Aerovate Therapeutics, Inc. (AVTE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.3700+0.0500 (+2.16%)
At close: 04:00PM EDT
2.4000 +0.03 (+1.27%)
After hours: 05:04PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
-
Operating Expense
94,217
81,409
53,237
23,022
8,889
-
Operating Income
-94,217
-81,409
-53,237
-23,022
-8,889
-
Net Non Operating Interest Income Expense
6,344
5,945
1,830
65
-75
-
Other Income Expense
-8
-1
-79
-3
-647
-
Pretax Income
-87,881
-75,465
-51,486
-22,960
-9,611
-
Tax Provision
-
56
25
3
0
-
Net Income Common Stockholders
-87,937
-75,521
-51,511
-22,985
-9,764
-
Diluted NI Available to Com Stockholders
-87,937
-75,521
-51,511
-22,985
-9,764
-
Basic EPS
-2.74
-2.87
-2.10
-1.87
-40.17
-
Diluted EPS
-2.74
-2.87
-2.10
-1.87
-40.17
-
Basic Average Shares
25,557
26,332
24,472
12,294
243.076
-
Diluted Average Shares
25,557
26,332
24,472
12,294
243.076
-
Total Operating Income as Reported
-94,217
-81,409
-53,237
-23,022
-8,889
-
Total Expenses
23,022
81,409
53,237
23,022
8,889
-
Net Income from Continuing & Discontinued Operation
-22,963
-75,521
-51,511
-22,963
-9,611
-
Normalized Income
-87,937
-75,521
-51,511
-22,963
-9,611
-
Interest Income
6,344
5,945
1,830
65
-
-
Interest Expense
-
-
-
-
75
0
Net Interest Income
6,344
5,945
1,830
65
-75
-
EBIT
-94,217
-81,409
-53,237
-23,022
-8,889
-
EBITDA
-94,108
-81,313
-53,169
-23,007
-8,888
-
Reconciled Depreciation
109
96
68
15
1
-
Net Income from Continuing Operation Net Minority Interest
-87,937
-75,521
-51,511
-22,963
-9,611
-
Normalized EBITDA
-94,108
-81,313
-53,169
-23,007
-8,888
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-